Evaluated articles

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

1. Adeola Fowotade
2. Folasade Bamidele
3. Boluwatife Egbetola
4. Adeniyi F. Fagbamigbe
5. Babatunde A. Adeagbo
6. Bolanle O. Adefuye
7. Ajibola Olagunoye
8. Temitope O. Ojo
9. Akindele O. Adebiyi
10. Omobolanle I. Olagunju
11. Olabode T. Ladipo
12. Abdulafeez Akinloye
13. Adedeji Onayade
14. Oluseye O. Bolaji
15. Steve Rannard
16. Christian Happi
17. Andrew Owen
18. Adeniyi Olagunju

Reviewed by ScreenIT

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes

1. Colin Pawlowski
2. Eli Silvert
3. John C O'Horo
4. Patrick J Lenehan
5. Doug Challener
6. Esteban Gnass
7. Karthik Murugadoss
8. Jason Ross
9. Leigh Speicher
10. Holly Geyer
11. A J Venkatakrishnan
12. Andrew D Badley
13. Venky Soundararajan

Reviewed by ScreenIT

RISK STRATIFICATION OF PATIENTS WITH COVID-19 DISEASE THROUGH THE USE OF CLINICAL SCORES IN AN EMERGENCY DEPARTMENT. A review of the literature

1. Simone Zanella
2. Mancosu Alena
3. Brugnolli Anna
4. Carrara Alessandro
5. Bevilacqua Anita
6. Marinelli Elisa
7. Ricci Nicola
8. Francesco Buccelletti

Reviewed by ScreenIT

The fall of vulnerability to sleep disturbances in evening chronotypes when working from home and its implications for depression

1. Federico Salfi
2. Aurora D’Atri
3. Giulia Amicucci
4. Lorenzo Viselli
5. Maurizio Gorgoni
6. Serena Scarpelli
7. Valentina Alfonsi
8. Michele Ferrara

Reviewed by ScreenIT

Croup during the Coronavirus Disease 2019 Omicron Variant Surge

1. Emine M. Tunҫ
2. Cassandra Koid Jia Shin
3. Etiowo Usoro
4. Siobhan E. Thomas-Smith
5. Indi Trehan
6. Russell T. Migita
7. Ashley E. Keilman

Reviewed by ScreenIT

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration

1. Sebastian Fiedler
2. Sean R. A. Devenish
3. Alexey S. Morgunov
4. Alison Ilsley
5. Francesco Ricci
6. Marc Emmenegger
7. Vasilis Kosmoliaptsis
8. Elitza S. Theel
9. John R. Mills
10. Anton M. Sholukh
11. Adriano Aguzzi
12. Akiko Iwasaki
13. Andrew K. Lynn
14. Tuomas P. J. Knowles

Reviewed by ScreenIT

Managing endothelial dysfunction in COVID ‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind , placebo‐controlled , randomized clinical trial

1. Kamal Matli
2. Abdulrahman Al Kotob
3. Wassim Jamaleddine
4. Soad Al Osta
5. Pascale Salameh
6. Rami Tabbikha
7. Nibal Chamoun
8. Ahmad Moussawi
9. Jean‐Michel Saad
10. Gibran Atwi
11. Tarik Abu Saad
12. Omar Jamal
13. Jacques Mokhbat
14. Georges Ghanem

Reviewed by ScreenIT

Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021–January 2022: A retrospective, population-based, matched cohort study

1. Vincent Auvigne
2. Sophie Vaux
3. Yann Le Strat
4. Justine Schaeffer
5. Lucie Fournier
6. Cynthia Tamandjou
7. Charline Montagnat
8. Bruno Coignard
9. Daniel Levy-Bruhl
10. Isabelle Parent du Châtelet

Reviewed by ScreenIT

Comparative evaluation of Oral lesions: “Tale - the Covid 19 Tells”

1. Rashmi Bhavasar
2. Namratha A. Ajith
3. Rahul Bhavasar
4. Arti Shah
5. Vivek Vaswani

Reviewed by ScreenIT

OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and Omicron

1. Zachary A. Weishampel
2. Janean Young
3. Mark Fischl
4. Robert J. Fischer
5. Irene Owusu Donkor
6. Jade C. Riopelle
7. Jonathan E. Schulz
8. Julia R. Port
9. Taylor A. Saturday
10. Neeltje van Doremalen
11. Jody D. Berry
12. Vincent J. Munster
13. Claude Kwe Yinda

Reviewed by ScreenIT

Real world performance of inactivated SARS-CoV-2 vaccine (CoronaVac) against infection, hospitalization and death due to COVID-19 in adult population in Indonesia

1. Anton Suryatma
2. Raras Anasi
3. Miko Hananto
4. Asep Hermawan
5. Ririn Ramadhany
6. Irene Lorinda Indalao
7. Agustiningsih Agustiningsih
8. Ely Hujjatul Fikriyah
9. Kristina Lumban Tobing
10. Teti Tejayanti
11. Rustika Rustika
12. Pandji Wibawa Dhewantara

Reviewed by ScreenIT

1. Michal Chudzik
2. Anna Cender
3. Robert Mordaka
4. Jacek Zielinski
5. Joanna Katarzynska
6. Andrzej Marcinek
7. Jerzy Gebicki

Reviewed by ScreenIT

Unraveling the Enzymatic Mechanism of the SARS-CoV-2 RNA-Dependent-RNA-Polymerase. An Unusual Active Site Leading to High Replication Rates

1. Emmanuelle Bignon
2. Antonio Monari

Reviewed by ScreenIT

WITHDRAWN: SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer’s-like neuropathology

1. Wei-Bin Shen
2. Montasir Elahi
3. James Logue
4. Penghua Yang
5. Lauren Baracco
6. E. Albert Reece
7. Bingbing Wang
8. Ling Li
9. Thomas G Blanchard
10. Zhe Han
11. Robert A Rissman
12. Matthew B Frieman
13. Peixin Yang

Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

Fatality assessment and variant risk monitoring for COVID-19 using three new hospital occupancy related metrics

1. Ping-Wu Zhang
2. Steven H. Zhang
3. Wei-Feng Li
4. Casey J. Keuthan
5. Shuaizhang Li
6. Felipe Takaesu
7. Cynthia A. Berlinicke
8. Jun Wan
9. Jing Sun
10. Donald J. Zack

Reviewed by ScreenIT

The HR concerns and coping mechanisms for enhancing workplace flexibility in the healthcare sector during the COVID-19 Pandemic: A systematic review.

1. Ajit Kerketta
2. Sathiyaseelan B.

Reviewed by ScreenIT

Humoral Antibody Kinetics with ChAdOx1-nCOV (Covishield ^TM ) and BBV-152 (Covaxin ^TM ) Vaccine among Indian Healthcare workers: A 6-month Longitudinal Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) Study

1. Awadhesh Kumar Singh
2. Sanjeev Ratnakar Phatak
3. Ritu Singh
4. Kingshuk Bhattacharjee
5. Nagendra Kumar Singh
6. Arvind Gupta
7. Arvind Sharma

Reviewed by ScreenIT

Transparency and reporting characteristics of COVID-19 randomized controlled trials

1. Philipp Kapp
2. Laura Esmail
3. Lina Ghosn
4. Philippe Ravaud
5. Isabelle Boutron

Reviewed by ScreenIT

Increase in coercive measures in psychiatric hospitals in Germany during the COVID-19 pandemic

1. Erich Flammer
2. Frank Eisele
3. Sophie Hirsch
4. Tilman Steinert

Reviewed by ScreenIT

Early guidance for Sars-Cov-2 health policies in India: Social Distancing amidst Vaccination and Virus Variants ^*

1. Yi Zhang
2. Sanjiv Kapoor

Reviewed by ScreenIT